Original Research
Accepted on 14 May 2025
Significance of the Peripheral blood Treg/Th17 ratio as a prognostic immune biomarker in newly diagnosed multiple myeloma and Its correlation with 1q21 Gain/Amplification
in Cancer Immunity and Immunotherapy